SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-020210
Filing Date
2020-07-23
Accepted
2020-07-23 16:32:30
Documents
1
Period of Report
2020-07-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7865
  Complete submission text file 0000899243-20-020210.txt   10305
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Issuer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ONCTERNAL THERAPEUTICS, INC. 3525 DEL MAR HEIGHTS ROAD #821 SAN DIEGO CA 92130-2122
Business Address C/O ONCTERNAL THERAPEUTICS, INC. 3525 DEL MAR HEIGHTS ROAD #821 SAN DIEGO CA 92130-2122 (858) 434-1113
Shanghai Pharmaceutical (USA) Inc. (Reporting) CIK: 0001778270 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-50549 | Film No.: 201043966

Mailing Address C/O ONCTEMAL THERAPEUTICS, INC. 12230 EL CAMINO REAL, SUITE 300 SAN DIEGO CA 92130
Business Address C/O ONCTEMAL THERAPEUTICS, INC. 12230 EL CAMINO REAL, SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Shanghai Pharmaceuticals Holding Co., Ltd. (Reporting) CIK: 0001814155 (see all company filings)

State of Incorp.: K3 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-50549 | Film No.: 201043967